KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,620,150 | -29.9% | 188,500 | +15.9% | 0.01% | -30.0% |
| Q2 2023 | $3,738,174 | -37.6% | 162,600 | -19.5% | 0.01% | -33.3% |
| Q1 2023 | $5,988,223 | +30.9% | 202,100 | +10.3% | 0.02% | +15.4% |
| Q4 2022 | $4,575,168 | +18.1% | 183,300 | +3.0% | 0.01% | +18.2% |
| Q3 2022 | $3,875,000 | -15.1% | 178,000 | -23.2% | 0.01% | -15.4% |
| Q2 2022 | $4,562,000 | +302.3% | 231,700 | +764.6% | 0.01% | +333.3% |
| Q1 2022 | $1,134,000 | +230.6% | 26,800 | +396.3% | 0.00% | +200.0% |
| Q4 2021 | $343,000 | – | 5,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |